1. C. Paquet, N. Privat, R. Kaci, M. Polivka, O. Dupont, S. Haik, J. L. Laplanche, J. J. Hauw, and F. Gray. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease. Acta Neuropathol, 2008. Note: Journal article. [WWW]



2. E. Criniere, G. Kaloshi, F. Laigle-Donadey, J. Lejeune, N. Auger, A. Benouaich-Amiel, S. Everhard, K. Mokhtari, M. Polivka, J. Y. Delattre, K. Hoang-Xuan, J. Thillet, and M. Sanson. MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities. J Neurooncol, 83:173-179, 2007. Note: Journal article. [WWW]



3. G. Kaloshi, A. Benouaich-Amiel, F. Diakite, S. Taillibert, J. Lejeune, F. Laigle-Donadey, M. A. Renard, W. Iraqi, A. Idbaih, S. Paris, L. Capelle, H. Duffau, P. Cornu, J. M. Simon, K. Mokhtari, M. Polivka, A. Omuro, A. Carpentier, M. Sanson, J. Y. Delattre, and K. Hoang-Xuan. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology, 68(21):1831-6, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/administration & dosage, Brain Neoplasms/*drug therapy/*genetics/physiopathology, *Chromosome Deletion, Chromosomes, Human, Pair 1/genetics, Chromosomes, Human, Pair 19/genetics, DNA Mutational Analysis, Dacarbazine/administration & dosage/*analogs & derivatives, Drug Resistance, Neoplasm/*genetics, Female, Gene Expression Regulation, Neoplastic/drug effects/genetics, Genetic Screening, Genotype, Glioma/*drug therapy/*genetics/physiopathology, Humans, Loss of Heterozygosity/genetics, Male, Middle Aged, Neoplasm Recurrence, Local/drug therapy/genetics, Retrospective Studies, Survival Rate, Treatment Outcome.



4. C. Dehais, F. Laigle-Donadey, Y. Marie, M. Kujas, J. Lejeune, A. Benouaich-Amiel, M. Pedretti, M. Polivka, K. H. Xuan, J. Thillet, J. Y. Delattre, and M. Sanson. Prognostic stratification of patients with anaplastic gliomas according to genetic profile. Cancer, 107(8):1891-7, 2006. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Brain Neoplasms/*genetics/mortality, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 10, Chromosomes, Human, Pair 9, Disease-Free Survival, Female, Glioma/*genetics/mortality, Humans, Loss of Heterozygosity, Male, Middle Aged, Molecular Diagnostic Techniques, Prognosis, Receptor, Epidermal Growth Factor/genetics, Survival Analysis, Tumor Suppressor Protein p53/metabolism.



5. M. Kujas, J. Lejeune, A. Benouaich-Amiel, E. Criniere, F. Laigle-Donadey, Y. Marie, K. Mokhtari, M. Polivka, M. Bernier, F. Chretien, A. Couvelard, L. Capelle, H. Duffau, P. Cornu, P. Broet, J. Thillet, A. F. Carpentier, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol, 58(2):322-6, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Brain Neoplasms/*genetics/pathology, *Chromosome Deletion, *Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 19, Female, Glioma/*genetics/pathology, Humans, Immunohistochemistry/methods, *Loss of Heterozygosity, Male, Middle Aged, Molecular Biology/methods.



6. K. Hoang-Xuan, L. Capelle, M. Kujas, S. Taillibert, H. Duffau, J. Lejeune, M. Polivka, E. Criniere, Y. Marie, K. Mokhtari, A. F. Carpentier, F. Laigle, J. M. Simon, P. Cornu, P. Broet, M. Sanson, and J. Y. Delattre. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol, 22(15):3133-8, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Astrocytoma/*drug therapy/*genetics, Brain Neoplasms/*drug therapy/*genetics, *Chromosome Deletion, Chromosomes, Human, Pair 1/*genetics, Dacarbazine/*analogs & derivatives/*therapeutic use, Female, Humans, Loss of Heterozygosity, Magnetic Resonance Imaging, Male, Middle Aged, Oligodendroglioma/*drug therapy/*genetics.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html